Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 26, Issue 6

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Investigational Drugs, Volume 26, Issue 6 (2017)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 26, Issue 6 (2017)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Volume 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Review

Investigational and experimental GnRH analogs and associated neurotransmitters

Zeev Blumenfeld

Pages: 661-667

Published online: 04 May 2017

AbstractforInvestigational and experimental GnRH analogs and associated neurotransmitters | Full Text | References | PDF (688 KB)

450 Views
9 CrossRef citations
0Altmetric

Review

Drugs in preclinical to phase II clinical development for the treatment of erectile dysfunction

Li Smith-Harrison, Nathan R. Starke, Ryan P. Smith & Jason R. Kovac

Pages: 669-675

Published online: 05 May 2017

AbstractforDrugs in preclinical to phase II clinical development for the treatment of erectile dysfunction | Full Text | References | PDF (581.7 KB)

175 Views
3 CrossRef citations
0Altmetric

Review

Investigational drugs for nasopharyngeal carcinoma

Brigette B.Y. Ma, Edwin P Hui & Anthony T.C. Chan

Pages: 677-685

Published online: 08 May 2017

AbstractforInvestigational drugs for nasopharyngeal carcinoma | Full Text | References | PDF (718.4 KB)

726 Views
20 CrossRef citations
0Altmetric

Review

Investigational dopamine antagonists for the treatment of schizophrenia

Sheng-Min Wang, Changsu Han, Soo-Jung Lee, Tae-Youn Jun, Ashwin A. Patkar, Prakash S. Masand & Chi-Un Pae

Pages: 687-698

Published online: 12 May 2017

AbstractforInvestigational dopamine antagonists for the treatment of schizophrenia | Full Text | References | PDF (1.4 MB)

1005 Views
15 CrossRef citations
0Altmetric

Review

Novel investigational drugs active as single agents in multiple myeloma

Mattia D’Agostino, Marco Salvini, Antonio Palumbo, Alessandra Larocca & Francesca Gay

Pages: 699-711

Published online: 08 May 2017

AbstractforNovel investigational drugs active as single agents in multiple myeloma | Full Text | References | PDF (1 MB)

895 Views
12 CrossRef citations
0Altmetric

Review

Anaplastic lymphoma kinase inhibitors in phase I and phase II clinical trials for non-small cell lung cancer

Niki Karachaliou, Mariacarmela Santarpia, Maria Gonzalez Cao, Cristina Teixido, Aaron E. Sosa, Jordi Berenguer, Alejandra Rodriguez Capote, Giuseppe Altavilla & Rafael Rosell

Pages: 713-722

Published online: 18 May 2017

AbstractforAnaplastic lymphoma kinase inhibitors in phase I and phase II clinical trials for non-small cell lung cancer | Full Text | References | PDF (905.3 KB)

486 Views
15 CrossRef citations
0Altmetric

Review

Investigational Janus kinase inhibitors in development for myelofibrosis

Prithviraj Bose, Abdallah Abou Zahr & Srdan Verstovsek

Pages: 723-734

Published online: 08 May 2017

AbstractforInvestigational Janus kinase inhibitors in development for myelofibrosis | Full Text | References | PDF (917.2 KB)

583 Views
9 CrossRef citations
0Altmetric

Discontinued Drugs Perspective

Article

Why do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010-2015

Dev Mehta, Robert Jackson, Gaurav Paul, Jiong Shi & Marwan Sabbagh

Pages: 735-739

Published online: 19 May 2017

AbstractforWhy do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010-2015 | Full Text | References | PDF (457.9 KB)

2251 Views
406 CrossRef citations
0Altmetric

Drug Evaluation

Article

Atrasentan for the treatment of diabetic nephropathy

Jesus Egido, Jorge Rojas-Rivera, Sebastian Mas, Marta Ruiz-Ortega, Ana Belen Sanz, Emilio Gonzalez Parra & Carmen Gomez-Guerrero

Pages: 741-750

Published online: 19 May 2017

AbstractforAtrasentan for the treatment of diabetic nephropathy | Full Text | References | PDF (999.2 KB)

827 Views
31 CrossRef citations
0Altmetric

Article

Olaparib for the treatment of breast cancer

Marie Robert, Jean-Sébastien Frenel, Carole Gourmelon, Anne Patsouris, Paule Augereau & Mario Campone

Pages: 751-759

Published online: 21 Apr 2017

AbstractforOlaparib for the treatment of breast cancer | Full Text | References | PDF (651.9 KB)

863 Views
15 CrossRef citations
0Altmetric

Article

Umeclidinium for the treatment of uncontrolled asthma

Matteo Ferrando, Diego Bagnasco, Fulvio Braido, Ilaria Baiardini, Giovanni Passalacqua, Francesca Puggioni, Gilda Varricchi & Giorgio Walter Canonica

Pages: 761-766

Published online: 21 Apr 2017

AbstractforUmeclidinium for the treatment of uncontrolled asthma | Full Text | References | PDF (813.8 KB)

671 Views
6 CrossRef citations
0Altmetric

Article

The neurogenic compound, NSI-189 phosphate: a novel multi-domain treatment capable of pro-cognitive and antidepressant effects

Roger S. McIntyre, Karl Johe, Carola Rong & Yena Lee

Pages: 767-770

Published online: 08 May 2017

AbstractforThe neurogenic compound, NSI-189 phosphate: a novel multi-domain treatment capable of pro-cognitive and antidepressant effects | Full Text | References | PDF (488 KB)

656 Views
12 CrossRef citations
0Altmetric

Article

Forodesine in the treatment of cutaneous T-cell lymphoma

Daniel J. Lewis & Madeleine Duvic

Pages: 771-775

Published online: 05 May 2017

AbstractforForodesine in the treatment of cutaneous T-cell lymphoma | Full Text | References | PDF (750.4 KB)

301 Views
8 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

VERVE-101, a CRISPR base-editing therapy designed to permanently inactivate hepatic PCSK9 and reduce LDL-cholesterol

Amanda J. Hooper et al.

Editorial | Published online: 15 Jun 2024

Free Access

Safety, pharmacokinetics and pharmacodynamics of SHR-1703, an innovative long-acting anti-interleukin-5 monoclonal antibody, in healthy subjects: a randomized, double-blind, dose-escalation, placebo-controlled phase I study

Ling Yang et al.

Article | Published online: 3 Jun 2024

The role of extracellular vesicles in immune cell exhaustion and resistance to immunotherapy

Ava Aghakhani et al.

Review Article | Published online: 30 May 2024

Clinical application and potential pluripotent effects of hepatocyte growth factor in spinal cord injury regeneration

Shogo Hashimoto et al.

Review Article | Published online: 29 May 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.26, Iss.6, 2017)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?